Cover Image

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer

Bioactive sphingolipid is clearly relevant to lung physiology. The relationship of the bioactive sphingolipid pathway to pulmonary disease has been studied in cellular, tissue, and animal model, including lung cancer models. The samples of 53 patients diagnosed with nonsmall cell lung carcinoma (NSC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nozomu Motono (Author), Yoshimichi Ueda (Author), Miyako Shimasaki (Author), Shun Iwai (Author), Yoshihito Iijima (Author), Katsuo Usuda (Author), Hidetaka Uramoto (Author)
Format:	Book
Published:	SAGE Publishing, 2021-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond
by: Ou SH
Published: (2011)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
by: Alessandro Cannavo, et al.
Published: (2017)

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
by: Steven F Powell, et al.
Published: (2009)

Early-stage multi-differentiated gastric carcinosarcoma and post-resection local recurrence: a case report
by: Akihiro Shioya, et al.
Published: (2020)

Sphingosine kinase 1 as an anticancer therapeutic target
by: Gao Y, et al.
Published: (2015)

Impact of symptom clusters on quality of life outcomes in patients from japan with advanced nonsmall cell lung cancers
by: Tamami Hamada, et al.
Published: (2016)

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe
by: Walleser S, et al.
Published: (2012)

Sphingosine Kinase 1 Plays an Important Role in Atorvastatin-Mediated Anti-Inflammatory Effect against Acute Lung Injury
by: Lan Wu, et al.
Published: (2021)

Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
by: Faez Iqbal Khan, et al.
Published: (2020)

Activation-induced cell death of dendritic cells is dependent on sphingosine kinase 1
by: Anja eSchwiebs, et al.
Published: (2016)

Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
by: Jitendra Shrestha, et al.
Published: (2022)

Inhibition of Sphingosine Kinase 1 Reduces Sphingosine-1-Phosphate and Exacerbates Amyloid-Beta-Induced Neuronal Cell Death in Mixed-Glial-Cell Culture
by: Tomoki Minamihata, et al.
Published: (2024)

Racial and Treatment Center Differences on Time to Treatment Initiation for Nonsmall Cell Lung Cancer Patients Receiving Radiation Therapy As an Initial Treatment
Published: (2022)

SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence
by: Yuehong Wang, et al.
Published: (2023)

Sphingosine Kinase: A Novel Putative Target for the Prevention of Infection-Triggered Preterm Birth
by: Vibhuti Vyas, et al.
Published: (2013)

Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH
by: David Montefusco, et al.
Published: (2022)

Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma
by: Christopher D. Green, et al.
Published: (2024)

High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer
by: Azadeh Sadat Nazouri, et al.
Published: (2017)

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers
by: Caolin Wang, et al.
Published: (2019)

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
by: Vicki Xie, et al.
Published: (2018)

Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
by: Sonam Roy, et al.
Published: (2020)

Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs
by: Amanda L. Aloia, et al.
Published: (2015)

Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice
by: Sun-Hye Shin, et al.
Published: (2019)

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
by: Heba Alshaker, et al.
Published: (2019)

Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax
by: Thao M. Nguyen, et al.
Published: (2024)

Multi-field-of-view deep learning model predicts nonsmall cell lung cancer programmed death-ligand 1 status from whole-slide hematoxylin and eosin images
by: Lingdao Sha, et al.
Published: (2019)

Effects of sphingosine and sphingosine analogues on the free radical production by stimulated neutrophils: ESR and chemiluminescence studies
by: A. Mouithys-Mickalad, et al.
Published: (1997)

SKI-II, an Inhibitor of Sphingosine Kinase, Ameliorates Antigen-Induced Bronchial Smooth Muscle Hyperresponsiveness, but Not Airway Inflammation, in Mice
by: Yoshihiko Chiba, et al.
Published: (2010)

Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
by: Junko Tsuchida, et al.
Published: (2017)

Basaloid carcinoma of the lung associated with central cavitation: a unique surgical case focusing on cytological and immunohistochemical findings
by: Yamada Sohsuke, et al.
Published: (2012)

Lysophosphatidylcholine Activates Extracellular-Signal-Regulated Protein Kinase and Potentiates Vascular Contractile Responses in Rat Aorta
by: Hiroshi Suenaga, et al.
Published: (2003)

Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial
by: So Yeon Lee, et al.
Published: (2024)

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
by: Wan Li, et al.
Published: (2022)

Study on Action Mode of Sphingosine 1-Phosphate in Rat Hepatocytes
by: Young-Jin Im, et al.
Published: (2005)

Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
by: Marco Piccoli, et al.
Published: (2023)

Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages.
by: Mohd Arish, et al.
Published: (2018)

Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma
by: Hyun Min Koh, et al.
Published: (2017)

Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
by: Bárbara González-Fernández, et al.
Published: (2017)

Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart
by: Naseer Ahmed, et al.
Published: (2017)

Differential Expression of Sphingosine-1-Phosphate Receptors in Abdominal Aortic Aneurysms
by: Z. Qu, et al.
Published: (2012)